<DOC>
	<DOCNO>NCT02106312</DOCNO>
	<brief_summary>To study feasibility reduce dose preoperative radiotherapy MLS ( Myxoid Liposarcomas ) 50 Gy 36 Gy maintain comparable clinicopathological response .</brief_summary>
	<brief_title>Dose Reduction Preoperative Radiotherapy Myxoid Liposarcomas</brief_title>
	<detailed_description>- A Bayesian approach consider analysis trial . The aim provide stop rule inefficacy new dose . - Two aspect important elucidate mechanism treatment : dynamic investigation perfusion vasculature . Apart participation dose reduction paragraph study , patient also ask undergo , clinically relevant dose point , dynamic contrast enhance ( DEC ) MRI scan separately tumor biopsy .</detailed_description>
	<mesh_term>Liposarcoma</mesh_term>
	<mesh_term>Liposarcoma , Myxoid</mesh_term>
	<criteria>1 . Age equal 18 year 2 . Biopsy proven MLS ( include reciprocal chromosomal translocation ( 12 ; 16 ) ( q13 ; p11 ) ; A primary sarcoma case nonmetastatic disease management curative intent ( regimen choose = 18 x 2 GY ) B case oligometastatic patient , metastasis may also irradiate dose 36 GY order postpone time interval next systemic chemotherapy . These patient usually operate upon total dose may also reach 12 time 3 Gy , convenience purpose ( see paragraph 10 radiobiological consideration ) . 3 . ECOG ( Eastern Cooperative Oncology Group ) PS ( Performance Status ) 02 4 . Patients must able ( physically , mentally socially ) complete series RT , follow observation period 46 week undergo surgery . 5 . Written inform consent 1 . Prior radiotherapy target area . 2 . Anticoagulant medication kind ; especially Ascal® ( derivates ) , coumarines ( Sintrom® Marcoumar® ) , heparin heparinlike formulation . ( Note : exclusion criterion apply patient consent translational research part study ; patient anticoagulant medication describe may take part dose reduction part study , repeat biopsy may take . ) 3 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Myxoid liposarcoma</keyword>
	<keyword>Soft tissue sarcoma</keyword>
</DOC>